Brent Herspiegel

Brent Herspiegel is an accomplished professional with extensive experience in the pharmaceutical and biotech industries. Since October 2007, Brent has served as the Chief Executive Officer of Herspiegel, a company specializing in commercialization services for pharmaceutical and biotech clients, focusing on strategic approaches, product launch, business intelligence, and product optimization. Prior to this role, Brent held key marketing positions as Executive Director of Marketing at Esprit Pharma from January 2006 to October 2007, and in marketing at Novo Nordisk Pharmaceuticals from 2003 to 2005, as well as at Eli Lilly from 1999 to 2003. Brent holds an MBA in Marketing and a BS in Biochemistry, both from McMaster University, earning the MBA degree between 1996 and 1998 and the BS degree from 1989 to 1993.